GABRIELA GALVAO

Dr. GABRIELA GALVAO

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Annals of Hepatology
Verified
Journal Article
Open access
LTLouise Torres
Louise Torres
ASAlice Schuch
Alice Schuch
LLLarisse Longo
Larisse Longo
BVBruna Bressan Valentini
Bruna Bressan Valentini
GGGABRIELA GALVAO
GABRIELA GALVAO
MAMario Reis Alvares-da-Silva
Mario Reis Alvares-da-Silva
Liver fibrosis is an important prognosis marker in non-alcoholic fatty liver disease (NAFLD). Biopsy has been considered the gold-standard method for measuring liver fibrosis; however, it is an invasive procedure. Non-invasive diagnostic tools have been developed, such as clinical scores and magnetic resonance elastography (MRE), which is the most accurate non-invasive method to determine liver fibrosis. Thus, the aim was to determine the NAFLD Fibrosis Score (NFS) and the Fibrosis-4 Score (FIB-4) cut-off points that best identify NAFLD patients at risk for developing liver fibrosis. Single-center cross-sectional study with prospective recruitment of NAFLD (training-cohort) and MAFLD (validation-cohort) patients undergoing MRE. The NFS and the FIB-4 cut-off points that best-differentiated patients with fibrosis, using the MRE as the standard method, were determined. Two cohorts were analyzed, a training cohort that included the initial 183 patients with NAFLD and a validation cohort that included 289 patients. In the training cohort, 60.1% had mild steatosis and 11.5% had liver fibrosis ≥ F1 by MRE. ROC curves were developed for FIB-4 and NFS, and the cut-off points chosen were 1.505 (sensitivity=85% and specificity=86%) for FIB-4 and -0.835 (sensitivity=100% and specificity=70%) for NFS, showing greater specificity than the cut-off points currently used (51% and 76%, respectively). The two cohorts exhibited similar characteristics and similar sensitivity and specificity results for the chosen cut-off points. This study has shown cut-off points with greater specificity and excellent sensitivity to guide the indication for further liver evaluation by MRE in NAFLD patients.

1 November 2020 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
RGRafael D. Grando
Rafael D. Grando
VBVicente B. Brentano
Vicente B. Brentano
AZANA PAULA ZANARDO
ANA PAULA ZANARDO
FHFelipe T. Hertz
Felipe T. Hertz
LJLuís C. Anflor Júnior
Luís C. Anflor Júnior
MGMarcelo B. Gazzana
Marcelo B. Gazzana
COVID-19 is a new disease and the most common complication is pneumonia. The Radiological Society of North America (RSNA) proposed an expert consensus for imaging classification for COVID-19 pneumonia. To evaluate sensitivity, specificity, accuracy, and reproducibility of chest CT standards in the beginning of the Brazilian COVID-19 outbreak. Cross-sectional study performed from March 1st to April 14th, 2020. Patients with suspected COVID-19 pneumonia submitted to RT-PCR test and chest computed tomography (CT) were included. Two thoracic radiologists blinded for RT-PCR and clinical and laboratory results classified every patient scan according to the RSNA expert consensus. A third thoracic radiologist also evaluated in case of discordance, and consensus was reached among the three radiologists. A typical appearance was considered a positive chest CT for COVID-19 pneumonia. Sensitivity, specificity, positive and negative predictive values were calculated. Cohen’s kappa coefficient was used to evaluate intra- and inter-rater agreements. A total of 159 patients were included (mean age 57.9 ± 18.0 years; 88 [55.3%] males): 86 (54.1%) COVID-19 and 73 (45.9%) non-COVID-19 patients. Eighty (50.3%) patients had a positive CT for COVID-19 pneumonia. Sensitivity and specificity of typical appearance were 88.3% (95%CI, 79.9–93.5) and 94.5% (95%CI, 86.7–97.8), respectively. Intra- and inter-rater agreement were assessed (Cohen’s kappa = 0.924, P = 0.06; Cohen’s kappa=0.772, P = 0.05, respectively). Chest CT categorical classification of COVID-19 findings is reproducible and demonstrates high level of agreement with clinical and RT-PCR diagnosis of COVID-19. In RT-PCR scarcity scenarios or in equivocal cases, it may be useful for attending physicians in the evaluation of suspected COVID-19 pneumonia patients attended at the emergency unit.

16 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CSCarolina L. Schiavo
Carolina L. Schiavo
RBRogério Boff Borges
Rogério Boff Borges
SCStela M. J. Castro
Stela M. J. Castro
AWAnelise S. Wolmeister
Anelise S. Wolmeister
ASAndressa de Souza
Andressa de Souza
LSLuciana C. Stefani
Luciana C. Stefani
Background: The Brief Measure of Emotional Preoperative Stress (B-MEPS) was developed to evaluate the preoperative individual vulnerability to emotional stress. To obtain a refined version of B-MEPS suitable for an app approach, this study aimed: (i) to identify items with more discriminant properties; (ii) to classify the level of preoperative emotional stress based on cut-off points; (iii) to assess concurrent validity through correlation with the Central Sensitization Inventory (CSI) score; (iv) to confirm whether the refined version of B-MEPS is an adequate predictive measure for identification of patients prone to intense postoperative pain. Methods: We include 1016 patients who had undergone surgical procedures in a teaching hospital. The generalized partial credit model of item response theory and latent class model were employed, respectively, to reduce the number of items and to create cut-off points. We applied the CSI and assessed pain by Visual Analog Scale (0–10) and by the amount of postoperative morphine consumption. Results: The refined B-MEPS shows satisfactory reliability (Cronbach’s alpha 0.79). Preoperative emotional stress, according to the cut-off points, is classified into categories: low, intermediate or high stress. The refined B-MEPS exhibited a linear association with the CSI scores (r2 = 0.53, p < 0.01). Patients with higher levels of emotional stress displayed a positive association with moderate to severe pain and greater morphine consumption. Conclusion: The refined version of B-MEPS, along with an interface of easy applicability, assess emotional vulnerability at the bedside before surgery. This app may support studies focused on intervening with perioperative stress levels.

9 August 2023 in Tomography
Verified
Journal Article
Open access
PDF file
AZANA PAULA ZANARDO
ANA PAULA ZANARDO
VBVICENTE BRENTANO
VICENTE BRENTANO
RGRafael Domingos Grando
Rafael Domingos Grando
RRRafael Ramos Rambo
Rafael Ramos Rambo
FHFelipe Teixeira Hertz
Felipe Teixeira Hertz
CACristiano Feijó Andrade
Cristiano Feijó Andrade
Introduction: The study was designed to evaluate the frequency of detection and the characteristics of subsolid nodules (SSNs) in outpatients’ chest computed tomography (CT) scans from a private hospital in Southern Brazil. Methods: A retrospective analysis of all chest CT scans was performed in adult patients from ambulatory care (non-lung cancer screening population) over a thirty-day period. Inclusion criteria were age > 18 years and lung-scanning protocols, including standard-dose high-resolution chest CT (HRCT), enhanced CT, CT angiography, and low-dose chest CT (LDCT). SSNs main features collected were mean diameter, number, density (pure or heterogenous ground glass nodules and part-solid), and localization. TheLungRADS system and the updated Fleischner Society’s pulmonary nodules recommendations were used for categorization only for study purposes, although not specifically fitting the population. The presence of emphysema, as well as calcified and solid nodules were also addressed. Statistical analysis was performed using R software, categorial variables are shown as absolute or relative frequencies, and continuous variables as mean and interquartile ranges. Results: Chest computed tomography were performed in 756 patients during the study period (September 2019), and 650 met the inclusion criteria. The IQR for age was 53/73 years; most participants were female (58.3%) and 10.6% had subsolid nodules detected. Conclusions: The frequency of SSNs detection in patients in daily clinical practice, not related to screening populations, is not negligible. Regardless of the final etiology, follow-up is often indicated, given the likelihood of malignancy for persistent lesions.

13 December 2023 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
AZANA PAULA ZANARDO
ANA PAULA ZANARDO
VBVicente Bohrer Brentano
Vicente Bohrer Brentano
RGRafael Domingos Grando
Rafael Domingos Grando
RRRafael Ramos Rambo
Rafael Ramos Rambo
FHFelipe Teixeira Hertz
Felipe Teixeira Hertz
CACristiano Feijó Andrade
Cristiano Feijó Andrade
Objective: To investigate the detection of subsolid nodules (SSNs) on chest CT scans of outpatients before and during the COVID-19 pandemic, as well as to correlate the imaging findings with epidemiological data. We hypothesized that (pre)malignant nonsolid nodules were underdiagnosed during the COVID-19 pandemic because of an overlap of imaging findings between SSNs and COVID-19 pneumonia. Methods: This was a retrospective study including all chest CT scans performed in adult outpatients (> 18 years of age) in September of 2019 (i.e., before the COVID-19 pandemic) and in September of 2020 (i.e., during the COVID-19 pandemic). The images were reviewed by a thoracic radiologist, and epidemiological data were collected from patient-filled questionnaires and clinical referrals. Regression models were used in order to control for confounding factors. Results: A total of 650 and 760 chest CT scans were reviewed for the 2019 and 2020 samples, respectively. SSNs were found in 10.6% of the patients in the 2019 sample and in 7.9% of those in the 2020 sample (p = 0.10). Multiple SSNs were found in 23 and 11 of the patients in the 2019 and 2020 samples, respectively. Women constituted the majority of the study population. The mean age was 62.8 ± 14.8 years in the 2019 sample and 59.5 ± 15.1 years in the 2020 sample (p < 0.01). COVID-19 accounted for 24% of all referrals for CT examination in 2020. Conclusions: Fewer SSNs were detected on chest CT scans of outpatients during the COVID-19 pandemic than before the pandemic, although the difference was not significant. In addition to COVID-19, the major difference between the 2019 and 2020 samples was the younger age in the 2020 sample. We can assume that fewer SSNs will be detected in a population with a higher proportion of COVID-19 suspicion or diagnosis.

1 December 2025 in Lung Cancer: Targets and Therapy
Verified
Journal Article
Open access
GGGABRIELA GALVAO
GABRIELA GALVAO
JSJônatas Fávero Prietto dos Santos
Jônatas Fávero Prietto dos Santos
YHYing-Han Hsu
Ying-Han Hsu
PRPatrik Rogalla
Patrik Rogalla
Background: Pulmonary nodular lymphoid hyperplasia is a rare benign lymphoproliferative disorder. Patients are commonly asymptomatic. Its radiological presentation is characterized by peripheral single nodular lesion, multiple nodules or mass-like consolidation. Therefore, it can mimic other more frequent pulmonary diseases, such as lung cancer and pulmonary lymphoma. The diagnosis is often late, relying on histopathological findings. Case Presentation: We report a case of a 66-year-old woman who presented with cough and upper respiratory tract symptoms. Chest CT revealed a mass in the right lower lobe, mediastinal and hilar enlarged lymph nodes and multifocal ground-glass and part solid nodules. PET-CT findings were concerning for primary lung malignancy. She underwent transbronchial needle aspiration biopsy of the enlarged lymph nodes and pulmonary mass. The results were negative for malignancy, but immunophenotyping by flow cytometry was concerning for a lymphoproliferative disorder. For this reason, a percutaneous CT-guided transthoracic core needle biopsy of the mass was performed. Immunophenotypic features of lymphoma were not identified. Overall findings were suggestive of nodular lymphoid hyperplasia. The follow-up chest CT showed near complete resolution of the mass with a residual ground-glass lesion and stability of the enlarged lymph nodes, ground-glass and part solid nodules. Conclusion: Pulmonary nodular lymphoid hyperplasia is an uncommon lung disorder, usually detected incidentally on chest imaging. Its radiological features can mimic lung cancer and other more prevalent pulmonary diseases. Therefore, a multidisciplinary approach, including histopathological confirmation is essential for an accurate diagnosis. Although rare, it should be considered in the differential diagnosis of pulmonary malignancies.